GSK-3β-specific deficiency dramatically inhibits apoptosis after myocardial infarction (MI), and conditional deletion of GSK-3α in the heart reduces the Bax/Bcl-2 ratio and apoptosis (Xia et al., 2016). This evidence concerns the gene BCL2 and myocardial infarction.